Is SARS Just ARDS?

JAMA

Volumn 290, Issue 3, 2003, Pages 397-399

  Rubenfeld, Gordon D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CORTICOSTEROID; IMMUNOGLOBULIN;

ADULT; BRONCHOSPASM; CASE REPORT; CLINICAL FEATURE; CRITICAL ILLNESS; EDITORIAL; FEMALE; HUMAN; INFECTION PREVENTION; INTENSIVE CARE UNIT; LUNG EDEMA; LUNG INJURY; MORTALITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY TRACT DISEASE; RISK FACTOR; SEVERE ACUTE RESPIRATORY SYNDROME; SYMPTOMATOLOGY; TREATMENT OUTCOME; VIRUS PNEUMONIA; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; DIFFERENTIAL DIAGNOSIS; MICROBIOLOGY; NOTE; RESEARCH;

DIAGNOSIS, DIFFERENTIAL; HUMANS; INTENSIVE CARE UNITS; RESEARCH; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 0037925644     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.3.397-a     Document Type: Editorial

References (30)

1. Luhr OR, Antonsen K, Karlsson M, et al. Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland: The ARF Study Group. Am J Respir Crit Care Med. 1999;159:1849-1861.
2. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163: 1730-1754.
3. Klinger JR, Sanchez MP, Curtin LA, Durkin M, Matyas B. Multiple cases of life-threatening adenovirus pneumonia in a mental health care center. Am J Respir Crit Care Med. 1998;157:645-649.
4. Moolenaar RL, Dalton C, Lipman HB, et al. Clinical features that differentiate hantavirus pulmonary syndrome from three other acute respiratory illnesses. Clin Infect Dis. 1995;21:643-649.
5. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet. 1967;2:319-323.
6. Pearson H, Animal studies hint at staying power of SARS. Nature. 2003;423: 370-371.
7. Fowler RA, Lapinsky SE, Hallett D, et al. Critically ill patients with severe acute respiratory syndrome. JAMA. 2003;290:367-373.
8. Lew TWK, Kwek T-K, Tai D, et al. Acute respirtory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA. 2003;290:374-380.
9. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 pt 1):818-824.
10. Eisner MD, Thompson T, Hudson LD, et al. Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;164: 231-236.
11. Luhr OR, Karlsson M, Thorsteinsson A, Rylander C, Frostell CG. The impact of respiratory variables on mortality in non-ARDS and ARDS patients requiring mechanical ventilation. Intensive Care Med. 2000;26:508-517.
12. Heffner JE, Brown LK, Barbieri CA, Harpel KS, DeLeo J. Prospective validation of an acute respiratory distress syndrome predictive score. Am J Respir Crit Care Med. 1995;152(5 pt 1):1518-1526.
13. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med. 2001;134:298-314.
14. Maunder R, Hunter J, Vincent L, et al. The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital. CMAJ. 2003; 168:1245-1251.
15. Goss CH, Brower RG, Hudson LD, Rubenfeld GD. Incidence of acute lung injury in the United States. Crit Care Med. 2003;31:1607-1611.
16. National Organization for Rare Disorders. Available at: http://www.rarediseases.org/search/rdbdetail_abstract.html?disname= Acute%20Respiratory%20Distress%20Syndrome. Accessed verified June 25, 2003.
17. Rubenfeld GD. Epidemiology of acute lung injury. Crit Care Med. 2003;31(4 suppl):S276-S284.
18. Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003;348:683-693.
19. Rubenfeld GD, Caldwell E, Granton J, Hudson LD, Matthay MA. Interobserver variability in applying a radiographic definition for ARDS. Chest. 1999;116: 1347-1353.
20. Tobin MJ. Culmination of an era in research on the acute respiratory distress syndrome. N Engl J Med. 2000;342:1360-1361.
21. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome: The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342:1301-1308.
22. Drazen JM. Controlling research trials. N Engl J Med. 2003;348:1377-1380.
23. Steinbrook R. How best to ventilate? trial design and patient safety in studies of the acute respiratory distress syndrome. N Engl J Med. 2003;348:1393-1401.
24. Esteban A, Anzueto A, Frutos F, et al. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA. 2002; 287:345-355.
25. 2O before tidal volume reduction. Am J Respir Crit Care Med. 2003;167:A616.
26. Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon: medical and public health management: Working Group on Civilian Biodefense. JAMA. 2000;283:2281-2290.
27. Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon: medical and public health management: Working Group on Civilian Biodefense. JAMA. 1999;281:2127-2137.
28. Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a biological weapon: medical and public health management: Working Group on Civilian Biodefense. JAMA. 1999;281:1735-1745.
29. Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: medical and public health management. JAMA. 2001;285:2763-2773.
30. Ramstack T. Germ research gets urgent; bioterrorism fuels interest, funding of scientific projects. Washington Post. June 9, 2003: sect A:1.